In acute myeloid leukemia (AML), abnormal expression of m6A regulatory factors, including METL3, METTL14, FTO, ALKBH5, and IGF2BP1/2/3, can regulate the expression of MYC. This evidence concerns the gene IGF2BP1 and acute myeloid leukemia.